YCBD (STOCKS)
cbdMD, Inc. Common Stock
$0.689000
+0.003100 (+0.45%)
Prev close: $0.685900
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- T. Ronan Kennedy
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7.23M
- Employees
- 42
- P/E (TTM)
- -1.68
- P/B (TTM)
- 0.78
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q2)
|
$-0.08 | $-0.05 | -0.0290 | -56.86% |
|
Dec 2025 (Q1)
|
$-0.04 | $-0.06 | +0.0212 | +34.64% |
|
Mar 2025 (Q4)
|
$-0.17 | $-0.07 | -0.0986 | -138.10% |
|
Jun 2025 (Q3)
|
$-0.21 | $-0.02 | -0.1896 | -929.41% |
Financial Statements
| Revenues | $19.98M |
| Benefits Costs and Expenses | $22.64M |
| Cost Of Revenue | $8.12M |
| Costs And Expenses | $22.64M |
| Gross Profit | $11.87M |
| Operating Expenses | $14.54M |
| Operating Income/Loss | -$2.68M |
| Income/Loss From Continuing Operations After Tax | -$2.66M |
| Income/Loss From Continuing Operations Before Tax | -$2.66M |
| Interest Income/Expense After Provision For Losses | $21.23K |
| Interest Income/Expense Operating, Net | $21.23K |
| Net Income/Loss | -$2.66M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$2.66M |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.11M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $453.78K |
| Preferred Stock Dividends And Other Adjustments | $453.78K |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | $0.14 |
| Basic Average Shares | 17,145,699 |
| Assets | $12.25M |
| Current Assets | $8.38M |
| Inventory | $3.65M |
| Other Current Assets | $4.73M |
| Noncurrent Assets | $3.87M |
| Fixed Assets | $361.12K |
| Intangible Assets | $2.19M |
| Other Non-current Assets | $1.31M |
| Liabilities | $2.97M |
| Current Liabilities | $2.97M |
| Accounts Payable | $1.39M |
| Other Current Liabilities | $1.57M |
| Noncurrent Liabilities | $0.00 |
| Equity | $9.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.28M |
| Liabilities And Equity | $12.25M |
| Net Cash Flow From Operating Activities | -$2.48M |
| Net Cash Flow From Operating Activities, Continuing | -$2.48M |
| Net Cash Flow From Investing Activities | -$118.40K |
| Net Cash Flow From Investing Activities, Continuing | -$118.40K |
| Net Cash Flow From Financing Activities | $2.78M |
| Net Cash Flow From Financing Activities, Continuing | $2.78M |
| Net Cash Flow | $185.69K |
| Net Cash Flow, Continuing | $185.69K |
| Comprehensive Income/Loss | -$2.99M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$2.99M |
| Other Comprehensive Income/Loss | -$1.23M |